Bauman JR, Liu G, Preeshagul I, Liu SV, et al. Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]. Lung Cancer 2024 Nov 1:108000. doi: 10.1016/j.lungcan.2024.108000.
PMID: 39488462